Tizanidine Tablet
Product Images NDC 63629-8533

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63629-8533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tizanidine-1 (Tizanidine 1)

Chemical structure diagram of Tizanidine hydrochloride, showing its molecular rings and atoms, relevant to the active ingredient Tizanidine.*

FDA Label Image

Tizanidine-2 (Tizanidine 2)

A pharmacokinetic line graph showing plasma Tizanidine concentration (ng/mL) over 24 hours post-dosing. The graph compares 4 mg Tizanidine tablets and capsules taken with and without food, with time on the x-axis and plasma concentration on the y-axis, illustrating different concentration-time profiles for each condition.*

FDA Label Image

Tizanidine-3 (Tizanidine 3)

A line graph depicting the improvement in Ashworth Score over 6 hours post-dose for three groups: placebo, 8 mg tizanidine, and 16 mg tizanidine. The y-axis shows improvement scores ranging from 0 to -5, with time in hours on the x-axis. Both tizanidine doses show greater improvement compared to placebo, peaking between 1 and 3 hours.*

FDA Label Image

Tizanidine-4 (Tizanidine 4)

A line graph depicting improvement in Ashworth Score over time at three study points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The graph compares two groups: tizanidine (mean dose 28.8 mg) showing greater improvement with scores around -4 to -5, and placebo showing minimal improvement near 0 to -1. Error bars indicate variability at each point.*

FDA Label Image

Label (Lbl636298533)

Label for Tizanidine Tablets, USP 2 mg by Bryant Ranch Prepack. The label includes NDC 63629-8533-1, a barcode, and states the package contains 150 tablets. It warns that tablets are not interchangeable with capsules and provides storage instructions along with safety precautions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.